{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:12:10Z","timestamp":1790727130177,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jdin.2024.11.011","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:58:13Z","timestamp":1741881493000},"page":"62-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Expert consensus-based recommendations on the use of photodynamic therapy in actinic keratosis patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Vishal A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah T.","family":"Arron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Shane","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anokhi","family":"Jambusaria-Pahlajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie C.","family":"Zeitouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-7809","authenticated-orcid":false,"given":"Neal","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdin.2024.11.011_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1067\/mjd.2000.107497","article-title":"The nature of solar keratosis: a critical review in historical perspective","volume":"43","author":"Heaphy","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.11.011_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.abd.2019.10.004","article-title":"Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects","volume":"94","author":"Reinehr","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13555-014-0049-y","article-title":"Actinic keratosis: rationale and management","volume":"4","author":"Dodds","year":"2014","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.jdin.2024.11.011_bib5","first-page":"1099","article-title":"The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma","volume":"33","author":"Fuchs","year":"2007","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.jdin.2024.11.011_bib6","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3486","article-title":"Actinic keratosis diagnosis and increased risk of developing skin cancer: a 10-year cohort study of 17,651 patients in Sweden","volume":"100","author":"Guorgis","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdin.2024.11.011_bib7","first-page":"628","article-title":"Risk of skin cancer development in 672 patients affected by actinic keratoses","volume":"151","author":"Dika","year":"2016","journal-title":"Ital Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jdin.2024.11.011_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jamadermatol.2022.1034","article-title":"Risk of invasive cutaneous squamous cell carcinoma after different treatments for actinic keratosis: a secondary analysis of a randomized clinical trial","volume":"158","author":"Ahmady","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver,heart and lung transplant recipients 1970 to 2008 - a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jdin.2024.11.011_bib10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archdermatol.2009.276","article-title":"Incidence of and risk factors for skin cancer after heart transplant","volume":"145","author":"Brewer","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib11","first-page":"1","article-title":"The place of skin cancer screening in heart transplant recipient follow-up protocols: a case series","volume":"1","author":"Sundbom","year":"2014","journal-title":"Enliven Arch"},{"key":"10.1016\/j.jdin.2024.11.011_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-4632.2008.03711.x","article-title":"Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy","volume":"47","author":"Geusau","year":"2008","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.11.011_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40257-022-00674-3","article-title":"A review of existing therapies for actinic keratosis: current status and future directions","volume":"23","author":"Del Regno","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.11.011_bib14","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/j.jaad.2021.02.082","article-title":"Guidelines of care for the management of actinic keratosis","volume":"85","author":"Eisen","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.11.011_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjd.14498","volume":"175","author":"Reinhold","year":"2016","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.11.011_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096829","article-title":"A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe","volume":"9","author":"Vegter","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jdin.2024.11.011_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s13555-023-00888-1","article-title":"Advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer: a narrative review","volume":"13","author":"Farberg","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.36849\/JDD.2020.4930","article-title":"A randomized trial of broad area ALA-PDT for field cancerization mitigation in high-risk patients","volume":"19","author":"Piacquadio","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/CCID.S121323","article-title":"Patient satisfaction and reported outcomes on the management of actinic keratosis","volume":"10","author":"Khanna","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.11.011_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa1811850","article-title":"Randomized trial of four treatment approaches for actinic keratosis","volume":"380","author":"Jansen","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/14764170802056117","article-title":"Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes","volume":"10","author":"Tierney","year":"2008","journal-title":"J Cosmet Laser Ther"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib22","first-page":"1","article-title":"Review of photodynamic therapy in actinic keratosis and basal cell carcinoma","volume":"4","author":"Ericson","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13555-020-00425-4","article-title":"Management pearls on the treatment of actinic keratoses and field cancerization","volume":"10","author":"Piquero-Casals","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/bjd.15272","article-title":"Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis","volume":"176","author":"Holzer","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.11.011_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jdv.16844","article-title":"Chemical peelings for the treatment of actinic keratosis: a systematic review and meta-analysis","volume":"35","author":"Steeb","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jdin.2024.11.011_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: recommendations based on a methodological systematic review","volume":"31","author":"J\u00fcnger","year":"2017","journal-title":"Palliat Med"},{"issue":"4","key":"10.1016\/j.jdin.2024.11.011_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"},{"key":"10.1016\/j.jdin.2024.11.011_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/bjd.15884","article-title":"Photodynamic therapy is more effecitive than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial","volume":"178","author":"Togsverd-Bo","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib29","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.1057","article-title":"Ablative fractional laser-assisted low-irradiance photodynamic therapy for treatment of actinic keratoses in organ transplant recipients: a prospective, randomized, intraindividual controlled trial","volume":"102","author":"Lonsdorf","year":"2022","journal-title":"Acta Derm Venereol"},{"issue":"Suppl. 2","key":"10.1016\/j.jdin.2024.11.011_bib30","first-page":"8","article-title":"The importance of treating the field in actinic keratosis","volume":"31","author":"Stockfleth","year":"2017","journal-title":"JEADV"},{"issue":"11","key":"10.1016\/j.jdin.2024.11.011_bib31","first-page":"1241","article-title":"A controlled comparison study of topical fluourouracil 5% cream pre-treatment of aminolevulinic acid\/photodynamic therapy for actinic keratosis","volume":"14","author":"Tanghetti","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.11.011_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40257-018-0348-7","article-title":"Field cancerization therapies for management of actinic keratosis: a narrative review","volume":"19","author":"Jetter","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jid.2020.09.002","article-title":"Actinic keratoses: reconciling the biology of field cancerization with treatment paradigms","volume":"141","author":"Gilcrest","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.11.011_bib34","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2006.07520.x","article-title":"Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up","volume":"155","author":"Tschen","year":"2006","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2024.11.011_bib35","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1586\/era.10.154","article-title":"Recent advances in the prevention and treatment of skin cancer using photodynamic therapy","volume":"10","author":"Zhao","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1524-4725.2009.01384.x","article-title":"Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy","volume":"36","author":"Willey","year":"2010","journal-title":"Dermatol Surg"},{"issue":"10","key":"10.1016\/j.jdin.2024.11.011_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cancers8100090","article-title":"Photodynamic therapy for non-melanoma skin cancers","volume":"8","author":"Cohen","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jdin.2024.11.011_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/349526","article-title":"Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients","volume":"2013","author":"Wlodek","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jdin.2024.11.011_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000366546","article-title":"Conventional treatment of actinic keratosis: an overview","volume":"46","author":"Peris","year":"2015","journal-title":"Curr Probl Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1529-8019.2009.01294.x","article-title":"Therapeutic Hotline: facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis","volume":"23","author":"Bruscino","year":"2010","journal-title":"Dermatol Ther"},{"issue":"8","key":"10.1016\/j.jdin.2024.11.011_bib41","first-page":"925","article-title":"Current methods for photodynamic therapy in the US: comparison of MAL\/PDT and ALA\/PDT","volume":"12","author":"Lee","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib42","first-page":"137","article-title":"Photodynamic therapy for skin rejuvenation: review and summary of the literature--results of a consensus conference of an expert group for aesthetic photodynamic therapy","volume":"11","author":"Karrer","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjd.17148","article-title":"Local interventions for actinic keratosis in organ transplant recipients: a systematic review","volume":"180","author":"Heppt","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib44","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1365-2133.2012.11051.x","article-title":"Application of photodynamic therapy combined with pre-illumination microneedling in the treatment of actinic keratosis in organ transplant recipients","volume":"167","author":"Bencini","year":"2012","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.11.011_bib45","first-page":"E53","article-title":"Photodynamic therapy with 5-aminolevulinic acid 10% gel and red light for the treatment of actinic keratosis, nonmelanoma skin cancers, and acne: current evidence and best practices","volume":"14","author":"Zeitouni","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"issue":"12","key":"10.1016\/j.jdin.2024.11.011_bib46","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jdv.16017","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019 part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"10.1016\/j.jdin.2024.11.011_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdv.14091","article-title":"The importance of patient-centred care to overcome barriers in the management of actinic keratosis","volume":"31","author":"Cerio","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jdin.2024.11.011_bib48","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/09546634.2016.1178372","article-title":"Adherence to topical therapies in actinic keratosis: a literature review","volume":"27","author":"Foley","year":"2016","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.15107","article-title":"British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017","volume":"176","author":"de Berker","year":"2017","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2024.11.011_bib50","doi-asserted-by":"crossref","first-page":"888","DOI":"10.36849\/JDD.6078","article-title":"Advances and considerations in the management of actinic keratosis: an expert consensus panel report","volume":"20","author":"Rosso","year":"2021","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib51","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/jcm9051438","article-title":"Treatment motivations and expectations in patients with actinic keratosis: a German-wide multicenter, cross-sectional trial","volume":"9","author":"Steeb","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.jdin.2024.11.011_bib54","first-page":"1483","volume":"11","author":"Schmieder","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/09546634.2012.757285","article-title":"Patients' perceptions of topical treatments of actinic keratosis","volume":"25","author":"Esmann","year":"2014","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib56","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/bjd.14680","article-title":"Patient-reported adherence and persistence to topical treatments for actinic keratosis: a longitudinal diary study","volume":"175","author":"Erntoft","year":"2016","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.11.011_bib57","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.DSS.0000452662.69539.57","article-title":"Temperature-modulated photodynamic therapy for the treatment of actinic keratosis on the extremities: a pilot study","volume":"40","author":"Willey","year":"2014","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2340\/00015555-2612","article-title":"Pretreatment with 5-fluorouracil cream enhances the efficacy of daylight-mediated photodynamic therapy for actinic keratosis","volume":"97","author":"Nissen","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib59","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/jdv.15459","article-title":"Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis","volume":"33","author":"Heppt","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.jdin.2024.11.011_bib60","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/1346-8138.12310","article-title":"Comparative study for the effect of photodynamic therapy, imiquimod immunotherapy and combination of both therapies on 40 lesions of actinic keratosis in Japanese patients","volume":"40","author":"Tanaka","year":"2013","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjd.13222","article-title":"Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial","volume":"172","author":"Togsverd-Bo","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaad.2019.09.037","article-title":"Microneedling-assisted photodynamic therapy for the treatment of actinic keratosis: results from a systematic review and meta-analysis","volume":"82","author":"Steeb","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103050","article-title":"Sandpaper curettage: a simple method to improve PDT outcomes for actinic keratosis","volume":"40","author":"Heusinkveld","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib64","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/bjd.12343","article-title":"Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review","volume":"169","author":"Gupta","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib65","first-page":"161","article-title":"Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy","volume":"4","author":"Gilbert","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2024.11.011_bib66","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/pharmaceutics14081726","article-title":"Combination-based strategies for the treatment of actinic keratoses with photodynamic therapy: an evidence-based review","volume":"14","author":"Piaserico","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jdin.2024.11.011_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/102698","article-title":"Effective combination of photodynamic therapy and imiquimod 5% cream in the treatment of actinic keratoses: three cases","volume":"2013","author":"Held","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jdin.2024.11.011_bib68","article-title":"Refusal of retreatment with topical 5-fluorouracil among patients with actinic keratosis: qualitative analysis","volume":"15","author":"Singh","year":"2013","journal-title":"JMIR Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2024.11.011_bib69","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/j.1600-0625.2009.01001.x","article-title":"Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model","volume":"19","author":"Maisch","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pdpdt.2015.11.004","article-title":"Epidermal penetration and protoporphyrin IX formation of two different 5-aminolevulinic acid formulations in ex vivo human skin","volume":"14","author":"Schmitz","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"3","key":"10.1016\/j.jdin.2024.11.011_bib53","first-page":"32","article-title":"Safety and efficacy of aminolevulinic acid 10% topical gel versus aminolevulinic acid 20% topical solution followed by blue-light photodynamic therapy for the treatment of actinic keratosis on the face and scalp: a randomized, double-blind study","volume":"12","author":"Nestor","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/pho.2013.3616","article-title":"A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase","volume":"32","author":"Wunsch","year":"2014","journal-title":"Photomed Laser Surg"},{"issue":"3","key":"10.1016\/j.jdin.2024.11.011_bib72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/dth.12334","article-title":"Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis","volume":"29","author":"Genovese","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jdin.2024.11.011_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pdpdt.2016.08.005","article-title":"A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp","volume":"16","author":"Moggio","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/lsm.20277","article-title":"Do pulsed lasers produce an effective photodynamic therapy response?","volume":"38","author":"Strasswimmer","year":"2006","journal-title":"Lasers Surg Med"},{"issue":"4","key":"10.1016\/j.jdin.2024.11.011_bib75","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jaad.2019.09.010","article-title":"A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: bilaterally controlled, randomized trial of simultaneous versus conventional illumination","volume":"82","author":"Kaw","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2022.02.067","article-title":"Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment: an interventional cohort-controlled trial","volume":"87","author":"Bullock","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.11.011_bib77","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: a Delphi consensus statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/DSS.0000000000003677","article-title":"Field therapy for actinic keratosis: a structured review of the literature on efficacy, cost, and adherence","volume":"49","author":"Lampley","year":"2023","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jdv.15852","article-title":"Photodynamic therapy for the prevention and treatment of actinic keratosis\/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis","volume":"34","author":"Liew","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdin.2024.11.011_bib79","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/TP.0b013e318180731e","article-title":"Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study","volume":"86","author":"Wennberg","year":"2008","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib80","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.11.011_bib81","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.transproceed.2007.05.040","article-title":"Topical photodynamic therapy of actinic keratosis in renal transplant recipients","volume":"39","author":"Piaserico","year":"2007","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2133.2004.06054.x","article-title":"A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients","volume":"151","author":"Dragieva","year":"2004","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.11.011_bib83","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0378-6323.98075","article-title":"Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients","volume":"78","author":"Hasson","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"Suppl 1","key":"10.1016\/j.jdin.2024.11.011_bib85","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1080\/095466302317414672","article-title":"The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?","volume":"13","author":"Morton","year":"2002","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40266-022-00919-0","article-title":"Topical pharmacotherapy for actinic keratoses in older adults","volume":"39","author":"Calzavara-Pinton","year":"2022","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.jdin.2024.11.011_bib87","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jaad.2021.03.031","article-title":"Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study","volume":"85","author":"Ulrich","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib88","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/jdv.15185","article-title":"A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis","volume":"33","author":"Dirschka","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jdin.2024.11.011_bib89","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamadermatol.2021.2779","article-title":"Evaluation of long-term clearance rates of interventions for actinic keratosis: a systematic review and network meta-analysis","volume":"157","author":"Steeb","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2024.11.011_bib90","first-page":"1353","article-title":"Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT","volume":"13","author":"Berman","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.11.011_bib91","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jdv.12150","article-title":"Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy","volume":"28","author":"Basset-Seguin","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdin.2024.11.011_bib92","author":"Petrou"},{"issue":"7","key":"10.1016\/j.jdin.2024.11.011_bib93","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s13555-023-00936-w","article-title":"A review of MAL-PDT for the treatment strategy of actinic keratosis: broader clinical perspectives beyond the data and guideline recommendations","volume":"13","author":"Szeimies","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jdin.2024.11.011_bib94","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archderm.140.1.116","article-title":"Photodynamic therapy for nonmelanoma skin cancer \u2013 and more?","volume":"140","author":"Morton","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib95","first-page":"264","article-title":"A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer","volume":"30","author":"Marmur","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jdin.2024.11.011_bib96","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2004.05940.x","article-title":"Topical photodynamic therapy in clinical dermatology","volume":"150","author":"Kormeili","year":"2004","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2024.11.011_bib97","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.3390\/jcm12113813","article-title":"Poor adherence to self-applied topical drug treatment is a common source of low lesion clearance in patients with actinic keratosis-A cross-sectional study","volume":"12","author":"Koch","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdin.2024.11.011_bib98","first-page":"35","article-title":"Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream","volume":"8","author":"Shaffelburg","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.11.011_bib99","first-page":"275","article-title":"Photodynamic therapy effectively treats actinic keratoses without pre-illumination incubation time","volume":"16","author":"Gandy","year":"2017","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jaad.2023.03.056","article-title":"Comparative effectiveness of 5-aminolevulinic acid photodynamic therapy with no incubation versus one-hour incubation for the treatment of actinic keratosis: a randomized controlled trial","volume":"89","author":"Anvery","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.11.011_bib101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.140.1.33","article-title":"A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage","volume":"140","author":"Touma","year":"2004","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2024.11.011_bib102","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.36849\/JDD.7637","article-title":"The interventions to minimize pain during photodynamic therapy with 5-aminolevulinic acid for the treatment of cutaneous diseases","volume":"22","author":"Bhatia","year":"2023","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib103","first-page":"19","article-title":"In-office painless aminolevulinic acid photodynamic therapy: a proof of concept study and clinical experience in more than 100 patients","volume":"9","author":"Martin","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jdin.2024.11.011_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102415","article-title":"Field cancerization treatment: adjustments to an ALA red light photodynamic therapy protocol to improve pain tolerance","volume":"35","author":"Salvio","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"10.1016\/j.jdin.2024.11.011_bib105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/lsm.22118","article-title":"A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer","volume":"45","author":"Zeitouni","year":"2013","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jdin.2024.11.011_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103190","article-title":"Efficacy of two different methods of cold air analgesia for pain relief in PDT of actinic keratoses of the head region - a randomized controlled comparison study","volume":"40","author":"Silic","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"4","key":"10.1016\/j.jdin.2024.11.011_bib107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0781.2011.00595.x","article-title":"The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy","volume":"27","author":"Apalla","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"12","key":"10.1016\/j.jdin.2024.11.011_bib108","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jdv.13228","article-title":"Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe","volume":"29","author":"Lacour","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328725000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328725000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:36:58Z","timestamp":1762637818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328725000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":107,"alternative-id":["S2666328725000227"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.11.011","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert consensus-based recommendations on the use of photodynamic therapy in actinic keratosis patients","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}